Dividend Growth of Chemours Company (The)(CC)

Chemours Company (The)(CC) is having a Dividend Yield of 0.37% with the Annual cash Dividend per share of $0.12. The last quarter cash dividend per share pay out was $0.03. and the stock has a Indicated annual dividend of $0.12. Chemours Company (The)(CC) formally announced its most recent dividend on February 14, 2017 with a Dividend per share of $0.03. The new indicated annual dividend based on announced dividend per share is $0.12. The dividend yield based on the forward looking indicated annual dividend is 0.37%. Chemours Company (The)(CC) has the most recent dividend payout ratio of 0.12 with a 5-year average payout ratio of .

Chemours Company (The) (NYSE:CC) witnessed a decline in the market cap on Thursday as its shares dropped 2.39% or 0.78 points. After the session commenced at $31.94, the stock reached the higher end at $33 while it hit a low of $31.48. With the volume soaring to 3,866,860 shares, the last trade was called at $31.9. The company has a 52-week high of $33. The company has a market cap of $5,801 million and there are 181,834,320 shares in outstanding. The 52-week low of the share price is $3.52. Shares of The Chemours Company rose by 15.62% in the last five trading days and 27.5% for the last 4 weeks. The Chemours Company is up 44.87% in the last 3-month period. Year-to-Date the stock performance stands at 44.41%.

Currently the company Insiders own 0.78% of Chemours Company (The) shares according to the proxy statements. Institutional Investors own 74.71% of Chemours Company (The) shares. Company has reported several Insider transactions to the SEC, on May 18, 2016, Mark Newman (CFO) purchased 2,800 shares at 9.70 per share price.On May 6, 2016, Bradley J Bell (director) purchased 10,000 shares at 9.65 per share price.On Feb 29, 2016, Stephen D Newlin (director) purchased 10,000 shares at 4.95 per share price.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Chemours Co was Upgraded by Goldman to Buy on Feb 13, 2017. Chemours Co was Downgraded by Goldman to Neutral on Dec 12, 2016.

Chemours Co Last issued its quarterly earnings results on Feb 15, 2017. The company reported $0.08 EPS for the quarter, missing the analyst consensus estimate by $ -0.19. Analyst had a consensus of $0.27. The company had revenue of $1322.00 million for the quarter, compared to analysts expectations of $1241.59 million. The companys revenue was down -2.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.01 EPS.

Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The companys brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.

Chemours

Post Comment

*